In the News

---

AMP® Symposium Day 2: Schizophrenia
AMP Symposium
Feb. 5-6, 2024

Health Matters: Mental Health Edition–Evaluating Psychosis and Schizophrenia
Red River Radio
January 25, 2024

Early Indicators of Schizophrenia
Inside Schizophrenia Podcast
August 16, 2023

Early Intervention for Schizophrenia on the Horizon: Implications for Clinicians and Patients
Psychiatric Times
April 18, 2023

He Who Has Hope, Has Everything
Psychiatric Services
Feb. 15, 2023

New Voice of the Patient Report showcases the urgent need for better schizophrenia treatment
Schizophrenia and Psychosis Action Alliance
Feb. 7, 2023

Accelerating Medicines Partnership® Schizophrenia (AMP®SCZ): developing tools to enable early intervention in the psychosis high risk state
World Psychiatry
Jan. 14, 2023

Big Data for Psychosis Prediction
Psychiatric Times
May 21, 2022

Leaders of AMP Schizophrenia Describe International Collaboration to Find Biomarkers for Psychosis Risk
Psychiatric News
May 21, 2022

Leading Science With Lived Experience
Schizophrenia Bulletin
May 2, 2022

Predicting Psychosis: Field Moves From Assessment of Clinical Risk to Search for Biomarkers
Psychiatric News
April 25, 2022

Psychiatry Is Still Stuck in Freud’s Era. Big Data Can Revolutionize How We Care for Patients
Time
July 9, 2021

Foundation for the NIH Announces Large-scale Partnership to Expedite Treatments for Schizophrenia
Foundation for the National Institutes of Health
September 15, 2020

NIH public-private partnership to advance early interventions for schizophrenia
National Institutes of Health
September 15, 2020

Last Reviewed on April 22, 2024